Page 1635 - Saunders Comprehensive Review For NCLEX-RN
P. 1635

1. Description: Used only for pulmonary tuberculosis
                                             2. Cautions: Can affect blood levels of some medications,
                                                including oral contraceptives and warfarin, and some
                                                medications used to treat HIV infection

                                             3.        Side and adverse effects

                                                             a. Red-orange–colored body secretions
                                                             b. Hepatotoxicity
                                             4. Interventions
                                                             a. Obtain baseline liver function studies
                                                                and assess throughout therapy.

                                                             b.        Observe for hepatotoxic effects;

                                                                if they occur, withhold the medication
                                                                and notify the PHCP.
                                             5. Client education
                                                             a. That the medication can be taken
                                                                without regard to food
                                                             b. To avoid sunlight or ultraviolet light
                                                                until photosensitivity is determined
                                                             c. That red-orange–colored body
                                                                secretions may occur
                                C. Capreomycin sulfate
                                             1. Description
                                                             a. Mechanism of action is unknown.
                                                             b. Used to treat MDR-TB when significant
                                                                resistance to other medications is
                                                                expected
                                                             c. Administered intramuscularly

                                             2.        Contraindications and cautions

                                                             a. The risk of nephrotoxicity, ototoxicity,
                                                                and neuromuscular blockade is
                                                                increased with the use of
                                                                aminoglycosides or loop diuretics.
                                                             b. Used with caution in clients with renal
                                                                insufficiency, acoustic nerve
                                                                impairment, hepatic disorder,
                                                                myasthenia gravis, or parkinsonism
                                                             c. Not administered to clients receiving
                                                                streptomycin

                                             3.        Side and adverse effects

                                                             a. Nephrotoxicity
                                                             b. Ototoxicity
                                                             c. Neuromuscular blockade
                                             4. Interventions


                                                         1635
   1630   1631   1632   1633   1634   1635   1636   1637   1638   1639   1640